CRISPR: The Double-Edged Sword of Genetic Engineering
Episode Overview
CRISPR can edit genes by cutting out faulty DNA and replacing it with correct sequences. The technology holds promise for curing diseases like sickle cell anaemia. There are significant ethical concerns about the misuse of CRISPR. Regulations on who can access DNA sequences are currently lacking. Speculative uses include enhancing human capabilities or creating genetically modified soldiers.
CRISPR is like cutting and pasting DNA – it can fix mutations but also create unforeseen dangers
Ever wondered about the future of genetic engineering? In this episode of American Medicine Today, Dr. Neal Baer, a public health advocate and award-winning executive producer, joins the hosts to discuss the promises and pitfalls of CRISPR technology. CRISPR, a groundbreaking method for editing genes, has the potential to cure diseases like sickle cell anaemia but also poses risks, such as creating more dangerous viruses. Dr.
Baer explains how CRISPR works by cutting out faulty DNA and replacing it with correct sequences, akin to a cut-and-paste function. The conversation dives into the dual-use nature of CRISPR – its ability to both heal and harm. The hosts explore ethical concerns, especially regarding the lack of regulations on who can access DNA sequences, which could lead to unintended consequences. Dr. Baer also touches on speculative uses of CRISPR, like enhancing human capabilities or creating genetically modified soldiers.
The episode is a fascinating mix of science, ethics, and future possibilities that will leave you pondering the direction of genetic technology. Tune in for an eye-opening discussion that balances the excitement of medical breakthroughs with cautionary tales of their potential misuse.